Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.030
-0.060 (-5.50%)
At close: Nov 4, 2025, 4:00 PM EST
1.040
+0.010 (0.97%)
After-hours: Nov 4, 2025, 6:08 PM EST
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $13.43 million as of November 4, 2025. Its market cap has decreased by -35.43% in one year.
Market Cap
13.43M
Enterprise Value
10.32M
1-Year Change
-35.43%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $13.43M, a decrease of -88.35%. That is a compound annual growth rate of -24.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 11.20M | -45.63% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |